Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) released its quarterly earnings data on Monday. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.20, FiscalAI reports. Tactile Systems Technology had a net margin of 7.10% and a return on equity of 11.62%. The business had revenue of $85.70 million for the quarter, compared to analyst estimates of $85.52 million.
Here are the key takeaways from Tactile Systems Technology’s conference call:
- Q2 revenue rose 9% to $85.7 million, driven by 12% growth in lymphedema revenue to $73.6 million. Adjusted EBITDA increased 49% to $11.4 million as gross margin expanded 180 basis points to 76.3%.
- Lymphedema momentum remained strong, supported by favorable referral trends, improved sales-territory productivity, and increased Flexitouch adoption following Medicare’s updated coverage policy. Management said the initial disruption from Medicare prior authorization is beginning to moderate.
- AffloVest revenue declined 7% year over year to $12.1 million as several large DME partners reduced orders while working through elevated inventory ahead of the next-generation product launch. Management expects the impact to continue through Q3, with ordering patterns normalizing in Q4.
- The company lowered the top end of its 2026 revenue outlook to $360 million-$366 million, reflecting a more conservative airway-clearance forecast that is now roughly flat year over year. Adjusted EBITDA guidance was maintained at $49 million-$51 million despite the temporary AffloVest headwind and continued strategic investments.
- Tactile announced several longer-term growth initiatives, including an exclusive VA and Department of Defense distribution agreement for MyoSleeve, expanded diagnostic applications for LymphaTech targeted for FDA approval in 2027, and new clinical evidence supporting Flexitouch use in head-and-neck lymphedema.
Tactile Systems Technology Trading Down 17.1%
TCMD stock opened at $24.15 on Wednesday. The stock has a 50-day moving average price of $28.13 and a two-hundred day moving average price of $27.01. Tactile Systems Technology has a 1 year low of $12.12 and a 1 year high of $37.77. The stock has a market cap of $544.82 million, a PE ratio of 22.36 and a beta of 0.81.
Key Stories Impacting Tactile Systems Technology
- Positive Sentiment: TCMD reported second-quarter earnings of $0.34 per diluted share, well above the $0.14 analyst consensus, while revenue of $85.7 million slightly exceeded estimates. Revenue increased 8.6% year over year, and net income rose 142% to $7.8 million. Tactile Systems Technology Second Quarter 2026 Financial Results
- Positive Sentiment: Profitability and balance-sheet metrics improved: gross profit grew 11.2% to $65.3 million, operating profit reached $6.8 million, and the company ended the quarter with $69.9 million in cash while total liabilities declined. TCMD Q2 2026 Earnings Results
- Neutral Sentiment: BTIG maintained a Buy rating but reduced its price target from $40 to $39. The target still implies substantial upside, but the cut may temper investor enthusiasm. BTIG Analyst Update
- Neutral Sentiment: Reported short-interest data shows zero shares short both currently and in the prior period, with a zero-day short ratio. Because the figures include an invalid percentage change, they provide no meaningful trading signal.
- Negative Sentiment: Fiscal 2026 revenue guidance of $360 million to $366 million broadly brackets the $364.7 million consensus estimate, but the update did not provide a clear EPS outlook or an obvious upward revision. Investors may have viewed the outlook as insufficiently strong after the earnings beat. TCMD Earnings Report
- Negative Sentiment: Recent disclosed insider activity shows executives made no purchases and sold shares during the past six months. Such selling can raise caution about near-term valuation, although it does not necessarily indicate a change in the company’s fundamentals.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its position in Tactile Systems Technology by 2.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 186,936 shares of the company’s stock worth $2,471,000 after acquiring an additional 3,898 shares during the last quarter. Rhumbline Advisers lifted its position in shares of Tactile Systems Technology by 4.0% in the second quarter. Rhumbline Advisers now owns 37,780 shares of the company’s stock worth $383,000 after purchasing an additional 1,441 shares in the last quarter. American Century Companies Inc. boosted its holdings in Tactile Systems Technology by 11.2% during the second quarter. American Century Companies Inc. now owns 53,264 shares of the company’s stock worth $540,000 after purchasing an additional 5,364 shares during the last quarter. Prudential Financial Inc. boosted its holdings in Tactile Systems Technology by 3.5% during the second quarter. Prudential Financial Inc. now owns 24,360 shares of the company’s stock worth $247,000 after purchasing an additional 835 shares during the last quarter. Finally, Norges Bank acquired a new stake in Tactile Systems Technology in the 2nd quarter valued at $1,464,000. 83.43% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on TCMD shares. BTIG Research decreased their price target on shares of Tactile Systems Technology from $40.00 to $39.00 and set a “buy” rating for the company in a report on Tuesday. B. Riley Financial upgraded Tactile Systems Technology from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $32.00 to $36.00 in a report on Thursday, May 7th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Tactile Systems Technology in a report on Monday, August 3rd. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Tactile Systems Technology currently has a consensus rating of “Moderate Buy” and an average target price of $38.40.
Check Out Our Latest Report on Tactile Systems Technology
About Tactile Systems Technology
Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.
At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.
See Also
- Five stocks we like better than Tactile Systems Technology
- DraftKings’ Predictions Push Could Be the Bet That Matters Most
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
